CLR 131
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CLR 131, covering 2024-08-15 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas [Phase 1]